Publication | Open Access

Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract

New Effective TherapyChemoprevention StrategyAdvanced CancersMedicinePineal GlandImmunologyGastroenterologyPineal Indole MelatoninImmunotherapyOncologyRadiation OncologyTumor MicroenvironmentMelatonin